van der Heijden, MS
17  Ergebnisse:
Personensuche X
?
1

Genomic and Transcriptomic Characterization of Metastatic U..:

Nakauma, A ; Rijnders, M ; van Riet, J...
Urologic Oncology: Seminars and Original Investigations.  38 (2020)  12 - p. 910 , 2020
 
?
2

Predictive biomarkers for survival benefit with ramucirumab..:

van der Heijden, MS ; Powles, T ; Petrylak, D...
https://eprints.whiterose.ac.uk/186635/1/Predictive%20biomarkers%20for%20survival%20benefit%20with%20ramucirumab%20in%20urothelial%20cancer%20in%20the%20RANGE%20trial.pdf.  , 2022
 
?
4

Long non-coding RNAs identify a subset of luminal muscle-in..:

de Jong, Joep ; Liu, Y ; Robertson, AG...
de Jong , J , Liu , Y , Robertson , AG , Seiler , R , Groeneveld , CS , van der Heijden , MS , Wright , JL , Douglas , J , Dall'Era , M , Crabb , SJ , Rhijn , BWG , van Kessel , K , Davicioni , E , Castro , MAA , Lotan , Y , Zwarthoff , E , Black , PC , Boormans , J & Gibb , EA 2019 , ' Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis ' , Genome Medicine , vol. 11 , no. 1 , 60 . https://doi.org/10.1186/s13073-019-0669-z.  , 2019
 
?
5

The genomic landscape of metastatic castration-resistant pr..:

van Dessel, Lisanne ; van Riet, Job ; Smits, M...
van Dessel , L , van Riet , J , Smits , M , Zhu , YY , Hamberg , P , van der Heijden , MS , Bergman , AM , van Oort , IM , de Wit , R , Voest , EE , Steeghs , N , Yamaguchi , TN , Livingstone , J , Boutros , PC , Martens , J , Sleijfer , S , Cuppen , E , Zwart , W , van de Werken , H , Mehra , N & Lolkema , M 2019 , ' The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact ' , Nature Communications , vol. 10 , 5251 . https://doi.org/10.1038/s41467-019-13084-7.  , 2019
 
?
6

Clinical efficacy and biomarker analysis of neoadjuvant ate..:

Powles, T ; Kockx, M ; Rodriguez-Vida, A...
https://discovery.ucl.ac.uk/id/eprint/10097060/1/123145_1_art_file_919236_pjc4lj_convrt.pdf.  , 2019
 
?
8

Mechanistic target of rapamycin (MTOR) protein expression i..:

Winters, BR ; Vakar-Lopez, F ; Brown, L...
Winters , BR , Vakar-Lopez , F , Brown , L , Montgomery , B , Seiler , R , Black , PC , Boormans , J , Dall'Era , M , Davincioni , E , Douglas , J , Gibb , EA , Rhijn , BWG , van der Heijden , MS , Hsieh , AC , Wright , JL & Lam , HM 2018 , ' Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy ' , Urologic Oncology-Seminars and Original Investigations , vol. 36 , no. 7 , 342.e7 . https://doi.org/10.1016/j.urolonc.2018.03.016.  , 2018
 
?
 
?
12

Identification of susceptibility pathways for the role of c..:

Ji, X ; Bossé, Y ; Landi, MT...
Nature communications, 2018, 9 (1), pp. 3221 - ?.  , 2020
 
?
13

Protein-altering germline mutations implicate novel genes r..:

Ji, X ; Mukherjee, S ; Landi, MT...
Nature communications, 2020, 11 (1), pp. 2220 - ?.  , 2020
 
?
15

Protein-altering germline mutations implicate novel genes r..:

Ji, X ; Mukherjee, S ; Landi, MT...
https://eprints.whiterose.ac.uk/161227/1/Protein-altering%20germline%20mutations%20implicate%20novel%20genes%20related%20to%20lung%20cancer%20development.pdf.  , 2020
 
1-15